2024 Year in Review: Advancing Advocacy, Research, and Support
Reflecting on a Year of Growth, Resilience, and Community Impact As we close 2024, the …
Amy Wood
Meet Lennox: A Little Fighter with a Big Heart
How a Handheld Blood Analyzer Can Bring Freedom and Hope to His Family At just …
Shedding Light on the Health Challenges of Craniopharyngioma Survivors
New Insights from the Hypothalamic-Pituitary Brain Tumor Patient Registry Craniopharyngioma (CP) survivors face a range …
Levi’s Journey to the Stars
How a Handheld Blood Analyzer is Transforming His Life At the Raymond A. Wood Foundation, …
Dancing Through Challenges: Peter’s Story
Peter, age 9, Receives a Handheld Blood Analyzer for Management of Arginine Vasopressin Deficiency (AVP-D) …
The Raymond A. Wood Foundation and NORD® Launch Natural History Study of Rare Hypothalamic-Pituitary Brain tumors.
Research study is open to participants worldwide to advance understanding and treatments these rare diseases …
Recap: Pituitary Brain Tumor Family Conference 2023 – Advocacy, Connection, and Growth
Overview In the heart of Philadelphia, the Raymond A. Wood Foundation hosted the 5th Annual …
Empowering Families: Nathan’s Journey with Craniopharyngioma and Diabetes Insipidus
Meet Nathan Johnson: A Brave Warrior, Age 5, Fighting Against Craniopharyngioma In May of 2021, …
Innovating in Diabetes Insipidus Management: A Breakthrough in Blood Sodium Testing
Introduction Managing diabetes insipidus just got a significant boost, thanks to the groundbreaking work of …
Raymond A. Wood Foundation Reveals Caregiver Burden in Pioneering Craniopharyngioma Study
The Raymond A. Wood Foundation recently published its first research study entitled “Caregiver burden and …
